Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of recurrent fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Imminent risk of fracture after fracture.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Increased risk of hip fracture among spouses-evidence of a homogamy effect.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

The T -786C, G894T, and Intron 4 VNTR (4a/b) Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Prostate Cancer Cases.

Genetika·2016

Related Experiment Videos

Reducing uncertainty in health-care resource allocation.

T Simonsson1, K Sjölund, P Bümming

  • 1Department of Biomedicine, Sahlgrenska Academy at Göteborg University, Göteborg SE-405 30, Sweden.

British Journal of Cancer
|May 24, 2007
PubMed
Summary

This study introduces a new method using continuous hazard functions for survival data analysis. This approach optimizes cancer drug pricing, improving patient access, public spending, and pharmaceutical profits.

Related Experiment Videos

Area of Science:

  • Health Economics
  • Biostatistics
  • Pharmacoeconomics

Background:

  • Optimizing health intervention outcomes is crucial for policymakers.
  • Limited healthcare resources and rising cancer drug prices necessitate improved outcome estimation methods.
  • New cancer drugs, like imatinib mesylate, require robust evaluation frameworks.

Purpose of the Study:

  • To introduce a novel methodology for analyzing survival data using continuous hazard functions.
  • To enable more precise estimations of survival outcomes for various treatment options.
  • To demonstrate the application of this methodology in optimizing adjuvant cancer drug pricing.

Main Methods:

  • Development of a general methodology employing continuous hazard functions for survival data analysis.
  • Application of the methodology to calculate outcomes for adjuvant gastrointestinal stromal tumour treatment with imatinib mesylate.
  • Analysis of survival data to assess treatment option outcomes and drug pricing strategies.

Main Results:

  • Continuous hazard functions provide more precise survival outcome estimations.
  • Optimal drug pricing, informed by this methodology, can create win-win scenarios.
  • Calculations show improved drug availability, efficient public expenditure, and increased pharmaceutical profits.

Conclusions:

  • The methodology reduces uncertainty in healthcare resource allocation.
  • Continuous hazard function analysis is valuable for drug price negotiations and health intervention threshold investigations.
  • This approach offers benefits for policymakers, the pharmaceutical industry, payers, and clinicians.